Beximco Pharmaceuticals Limited (LON:BXP - Get Free Report)'s stock price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 43.57 ($0.59) and traded as high as GBX 46.50 ($0.63). Beximco Pharmaceuticals shares last traded at GBX 45.45 ($0.62), with a volume of 3,953 shares changing hands.
Beximco Pharmaceuticals Stock Performance
The company has a quick ratio of 0.37, a current ratio of 2.13 and a debt-to-equity ratio of 12.47. The firm's 50 day moving average is GBX 44 and its two-hundred day moving average is GBX 39.67. The stock has a market cap of £207.44 million, a price-to-earnings ratio of 3.26 and a beta of 0.61.
About Beximco Pharmaceuticals
(
Get Free Report)
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands.
Further Reading
Before you consider Beximco Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Beximco Pharmaceuticals wasn't on the list.
While Beximco Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
